You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Aware of the Rare -- The New Dawn! Updates in Diagnosing and Managing Rare Hematologic Disorders

  • Authors: Drew Provan, MD, FRCP, FRCPath; Morag Griffin, MBChB, FRCPath; Alexander Röth, MD
  • CME Released: 2/9/2022
  • Valid for credit through: 2/9/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for hematologists and oncologists, pediatricians, and others involved in the care of patients with rare hematologic disorders.

The goal of this activity is to improve clinicians’ ability to accurately diagnose and provide personalized care for patients who present with clinical symptoms suggestive of rare hematologic disorders.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Recent clinical trial data evaluating treatments for rare hematologic disorders
    • Establishment of a diagnosis for patients with rare hematologic disorders
  • Have greater competence related to
    • Personalizing therapy selection for patients with rare hematologic disorders
  • Demonstrate greater confidence in their ability to
    • Improve care for patients with rare hematologic disorders


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Drew Provan, MD, FRCP, FRCPath

    Barts and The London School of Medicine
    Barts Health NHS Trust
    London, United Kingdom

    Disclosures

    Advisor or consultant for: Argenx; UCB
    Speaker or member of speakers bureau for: Amgen; Novartis; Sobi
    Stocks, stock options, or bonds from: GlaxoSmithKline

  • ​Morag Griffin, MBChB, FRCPath

    Department of Haematology 
    St James’s University Hospital 
    Leeds, United Kingdom 

    Disclosures

    Served as a speaker or a member of a speakers bureau for: Alexion Pharmaceuticals; SOBI  

  • Alexander Röth, MD

    Department of Haematology 
    and Stem Cell Transplantation 
    Essen University Hospital 
    Universidad de Duisburg-Essen 
    Essen, Germany 

    Disclosures

    Served as an advisor or consultant for: Alexion; Apellis; Argenx; Bioverativ; Biocryst; Novartis; Roche; Sanofi; Sobi 
    Served as a speaker or a member of a speakers bureau for: Alexion; Novartis; Roche; Sanofi; Sobi 
    Received grants for clinical research from: Roche 

Editor

  • Victoria Phoenix, BS

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Victoria Phoenix, BS, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Aware of the Rare -- The New Dawn! Updates in Diagnosing and Managing Rare Hematologic Disorders

Authors: Drew Provan, MD, FRCP, FRCPath; Morag Griffin, MBChB, FRCPath; Alexander Röth, MDFaculty and Disclosures

CME Released: 2/9/2022

Valid for credit through: 2/9/2023

processing....

Educational Impact Challenge

 
 
 

The goal of this activity is to improve clinicians’ ability to accurately diagnose and provide personalized care for patients who present with clinical symptoms suggestive of rare hematologic disorders.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print